Director Richard Koo to retire from Amphastar Board effective Sept 30, 2021

Amphastar Pharmaceuticals, Inc.

Richard Koo announced retirement from Board effective September 30, 2021; not due to any disagreement.
Koo served 18 years on the Board; departure planned and amicable.
No successor or additional board changes announced in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Richard Koo

Director

AMPH · Amphastar Pharmaceuticals, Inc.

Effective: 2021-09-30
Filed: August 10, 2021, 7:59 PM ET

On August 5, 2021, Richard Koo announced his retirement from the Board of Directors (the “Board”) of Amphastar Pharmaceuticals, Inc. (the “Company”) effective as of September 30, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Richard Koo retired as Director at Amphastar Pharmaceuticals, Inc..

Action: retired
Role: Director

Exact text from the filing

On August 5, 2021, Richard Koo announced his retirement from the Board of Directors (the “Board”) of Amphastar Pharmaceuticals, Inc. (the “Company”) effective as of September 30, 2021.

View on SEC.gov

Amphastar Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001297184-21-000051

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.